-+ 0.00%
-+ 0.00%
-+ 0.00%

MHRA Authorizes Cancer Treatment Variation With An Administration Time Of 3–5 Minutes; Approved New Under-The-Skin Injection Version Of Nivolumab (Opdivo)

Benzinga·04/30/2025 14:25:57
Listen to the news